Synthesis of a series of N6-substituted adenosines with activity against trypanosomatid parasites

European Journal of Medicinal Chemistry

Volumn 44, Issue 9, 2009, Pages 3665-3671

  Link, Andreas ^a   Heidler, Philipp ^b   Kaiser, Marcel ^c   Brun, Reto ^c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Adenosine; Nucleoside transporter; Polymer bound reagents; Transport proteins

Indexed keywords

ADENOSINE DERIVATIVE; MEMBRANE PROTEIN; PROTOZOAL PROTEIN; ADENOSINE; ANTITRYPANOSOMAL AGENT; DRUG DERIVATIVE;

ARTICLE; DRUG TARGETING; NONHUMAN; PROTEIN EXPRESSION; TRYPANOSOMA BRUCEI; AFRICAN TRYPANOSOMIASIS; ANIMAL; CHEMISTRY; DRUG EFFECT; IC 50; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TRYPANOSOMA RHODESIENSE;

ADENOSINE; ANIMALS; INHIBITORY CONCENTRATION 50; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 67650451162     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.02.010     Document Type: Article

References (37)

1. de Koning H.P., Bridges D.J., and Burchmore R.J. FEMS Microbiol. Rev. 29 (2005) 987-1020
2. In: Marr J.J., and Muller M. (Eds). Biochemistry and Molecular Biology of Parasites (1995), Academic Press, Inc., New York
3. Bridges D.J., Pitt A.R., Hanrahan O., Brennan K., Voorheis H.P., Herzyk P., de Koning H.P., and Burchmore R.J. Proteomics 8 (2008) 83-99
4. de Koning H.P. Trends Parasitol. 24 (2008) 345-349
5. de Koning H.P. Int. J. Parasitol. 31 (2001) 512-522
6. Lüscher A., Onal P., Schweingruber A.-M., and Maser P. Antimicrob. Agents Chemother. 51 (2007) 3895-3901
7. Golisade A., Wiesner J., Herforth C., Jomaa H., and Link A. Bioorg. Med. Chem. 10 (2002) 769-777
8. Herforth C., Wiesner J., Franke S., Golisade A., Jomaa H., and Link A. J. Comb. Chem. 4 (2002) 302-314
9. Herforth C., Wiesner J., Heidler P., Sanderbrand S., Van Calenbergh S., Jomaa H., and Link A. Bioorg. Med. Chem. 12 (2004) 755-762
10. Al-Salabi M.I., and de Koning H.P. Antimicrob. Agents Chemother. 49 (2005) 3682-3689
11. el Kouni M.H. Pharmacol. Ther. 99 (2003) 283-309
12. Gelb M.H., and Hol W.G. Science 297 (2002) 343-344
13. Verlinde C.L., Hannaert V., Blonski C., Willson M., Perie J.J., Fothergill-Gilmore L.A., Opperdoes F.R., Gelb M.H., Hol W.G., and Michels P.A. Drug Resist. Updat. 4 (2001) 50-65
14. Wallace L.J., Candlish D., Hagos A., Seley K.L., and de Koning H.P. Nucleosides, Nucleotides Nucleic Acids 23 (2004) 1441-1444
15. Dolezal K., Popa I., Hauserova E., Spichal L., Chakrabarty K., Novak O., Krystof V., Voller J., Holub J., and Strnad M. Bioorg. Med. Chem. 15 (2007) 3737-3747
16. Kim Y.A., Sharon A., Chu C.K., Rais R.H., Al Safarjalani O.N., Naguib F.N., and el Kouni M.H. Biochem. Pharmacol. 73 (2007) 1558-1572
17. Zhao H., Pagano A.R., Wang W.M., Shallop A., Gaffney B.L., and Jones R.A. J. Org. Chem. 62 (1997) 7832-7835
18. Petricci E., Botta M., Corelli F., and Mugnaini C. Tetrahedron Lett. 43 (2002) 6507-6509
19. Shao H., Zhang Q., Goodnow R., Chen L., and Tam S. Tetrahedron Lett. 41 (2000) 4257-4260
20. Todd M.H., Oliver S.F., and Abell C. Org. Lett. 1 (1999) 1149-1151
21. Todd M.H., Oliver S.F., and Abell C. Org. Lett. 1 (1999) 1687
22. Masala S., and Taddei M. Org. Lett. 1 (1999) 1355-1357
23. Salvino J.M., Kumar N.V., Orton E., Airey J., Kiesow T., Crawford K., Mathew R., Krolikowski P., Drew M., Engers D., Krolikowski D., Herpin T., Gardyan M., McGeehan G., and Labaudiniere R. J. Comb. Chem. 2 (2000) 691-697
24. Isbell J. J. Comb. Chem. 10 (2008) 150-157
25. Clayton C.E. EMBO J. 21 (2002) 1881-1888
26. Carter N.S., and Fairlamb A.H. Nature 361 (1993) 173-176
27. Baliani A., Bueno G.J., Stewart M.L., Yardley V., Brun R., Barrett M.P., and Gilbert I.H. J. Med. Chem. 48 (2005) 5570-5579
28. Sanchez M.A., Drutman S., van Ampting M., Matthews K., and Landfear S.M. Mol. Biochem. Parasitol. 136 (2004) 265-272
29. Al-Salabi M.I., Wallace L.J.M., Lüscher A., Maser P., Candlish D., Rodenko B., Gould M.K., Jabeen I., Ajith S.N., and de Koning H.P. Mol. Pharmacol. 71 (2007) 921-929
30. Stukenbrock H., Mussmann R., Geese M., Ferandin Y., Lozach O., Lemcke T., Kegel S., Lomow A., Burk U., Dohrmann C., Meijer L., Austen M., and Kunick C. J. Med. Chem. 51 (2008) 2196-2207
31. Yoshikawa N., Yamada S., Takeuchi C., Kagota S., Shinozuka K., Kunitomo M., and Nakamura K. Naunyn Schmiedebergs Arch. Pharmacol. 377 (2008) 591-595
32. de Koning H.P., and Jarvis S.M. Mol. Pharmacol. 56 (1999) 1162-1170
33. Natto M.J., Wallace L.J., Candlish D., Al-Salabi M.I., Coutts S.E., and de Koning H.P. Exp. Parasitol. 109 (2005) 80-86
34. Bookser B.C., and Raffaele N.B. J. Org. Chem. 72 (2007) 173-179
35. Kim Y.A., Sharon A., Chu C.K., Rais R.H., Al Safarjalani O.N., Naguib F.N.M., and el Kouni M.H. J. Med. Chem. 51 (2008) 3934-3945
36. Baltz T., Baltz D., Giroud C., and Crockett J. EMBO J. 4 (1985) 1273-1277
37. Räz B., Iten M., Grether-Buhler Y., Kaminsky R., and Brun R. Acta Trop. 68 (1997) 139-147